Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Carbylan Therapeutics Inc buy Akuma

Start price
€14.00
17.03.26 / 0%
Target price
-
17.03.27
Performance (%)
62.36%
Price
€23.39
10.08.26
Summary
This prediction is currently active. The BUY prediction by Akuma for Carbylan Therapeutics Inc has seen massive gains of 62.36%. This prediction currently runs until 17.03.27. The prediction end date can be changed by Akuma at any time. This prediction was marked as speculative and is excluded from Akuma's performance statistics.
Performance without dividends (%)
Name 1w 1m
Carbylan Therapeutics Inc - -
iShares Core DAX® -0,87 % 5,32 %
iShares Nasdaq 100 -0,38 % 1,98 %
iShares Nikkei 225® -1,68 % 1,95 %
iShares S&P 500 -0,65 % 2,07 %

Comments by Akuma for this prediction

In the thread Carbylan Therapeutics Inc diskutieren

Buy Carbylan Therapeutics Inc